ELITE PHARMACEUTICALS INC /NV/ Quarterly Operating Lease, Liability, Noncurrent in USD from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
Elite Pharmaceuticals Inc /Nv/ quarterly Operating Lease, Liability, Noncurrent history and growth rate from Q2 2019 to Q3 2024.
  • Elite Pharmaceuticals Inc /Nv/ Operating Lease, Liability, Noncurrent for the quarter ending September 30, 2024 was $1.74M.
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.74M Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $1.85M Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $1.96M Mar 31, 2024 10-Q 2024-11-14
Q3 2022 $2.16K -$937K -99.8% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $782K -$222K -22.1% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $836K +$797K +2051% Mar 31, 2022 10-K 2023-06-29
Q4 2021 $934K Dec 31, 2021 10-Q 2022-02-14
Q3 2021 $940K +$883K +1562% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $1M +$892K +795% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $38.9K -$128K -76.7% Mar 31, 2021 10-K 2022-06-29
Q3 2020 $56.5K -$217K -79.3% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $112K -$212K -65.4% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $167K Mar 31, 2020 10-K 2021-06-14
Q4 2019 $221K Dec 31, 2019 10-Q 2020-02-10
Q3 2019 $273K Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $325K Jun 30, 2019 10-Q 2019-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.